AERI

Aerie Pharmaceuticals, Inc.
AERI

Overview Fund Activity
Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

136 hedge funds and large institutions have $437M invested in Aerie Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 38 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
136
Holders Change
+7
Holders Change %
+5.43%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
48
Reduced
38
Closed
21
Calls
$123K
Puts
$163K
Net Calls
-$40K
Net Calls Change
-$671K

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$14.7M
2
Schroder Investment Management Group
2
Schroder Investment Management Group
United Kingdom
$21.4M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$9.01M
4
LCS
4
Levin Capital Strategies
New York
$13.1M
5
RHJA
5
Rice Hall James & Associates
California
$15.3M

Top Sellers

1
William Blair Investment Management
1
William Blair Investment Management
Illinois
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$28.6M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$23.3M
4
Ameriprise
4
Ameriprise
Minnesota
$12.9M
5
NHAS
5
Novo Holdings A/S
Denmark
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AGM
151
Alpine Global Management
New York
– -$90K -12,831 Closed
Mirae Asset Global Investments
152
Mirae Asset Global Investments
South Korea
– -$75K -10,673 Closed
DFCM
153
Dark Forest Capital Management
Puerto Rico
– -$38K -5,390 Closed
Lazard Asset Management
154
Lazard Asset Management
New York
– -$21K -3,048 Closed
WAM
155
Wolverine Asset Management
Illinois
– -$4K -626 Closed
3 4 5 6
7